Lv2
150 积分 2024-04-23 加入
Clinical Outcomes at 8-16 Weeks After Upadacitinib Initiation for Acute Severe Ulcerative Colitis: A Case Series in the United States
1天前
已完结
No Impact of Concomitant Medications on Efficacy and Safety of Biologics and Small Molecules for Ulcerative Colitis
1个月前
已完结
Association of Inflammatory Bowel Disease Incidence with Isotretinoin Usage: A Meta-Analysis and Systematic Review
3个月前
已完结
Association of Inflammatory Bowel Disease Incidence with Isotretinoin Usage: A Meta-Analysis and Systematic Review
3个月前
已完结
Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases
4个月前
已完结
JAK抑制剂治疗炎症性肠病有效性及安全性的Meta分析
5个月前
已完结
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
6个月前
已完结
Efficacy and Safety of Advanced Oral Small Molecules for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
6个月前
已完结
乌帕替尼(Upadacitinib, Rinvoq)
6个月前
已完结
Circulating 25-hydroxyvitamin D concentration can predict bowel resection risk among individuals with inflammatory bowel disease in a longitudinal cohort with 13 years of follow-up
7个月前
已完结
皖公网安备34019202002308
